According to a new study by Harvard researchers, the vast majority of yohimbe sold as a dietary supplement by mainstream retailers in the United States is mislabeled in a way that could pose a safety risk to consumers. Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, is lead author of the study.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure